Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Breaking: Uncle Sam Must Secure "The Seeds of Technology"]( [Learn more about this mega trend and one company hoping to meet demand.]( --------------------------------------------------------------- January 12, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Rare Earth Elements: The Workhorse of The Tech Revolution]( re the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are. [Read this free investor report to reveal who could benefit in 2024.]( --------------------------------------------------------------- [EyePoint Pharmaceuticals]( Ticker: [EYPT]( Recent Price: $20.36 Average Analyst Price Target: $41.00 (86.64%) Market Cap: $718.90M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 855,000 $17,051,100 2 Days Ago Recent Analyst Action: Zegbeh Jallah, analyst at Capital One Financial, reiterates coverage on [EyePoint Pharmaceuticals (EYPT)]( in the Healthcare sector with a Buy rating and a price target of $44 (1 month ago). Here are 3rd party ratings for [EYPT](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 26% (66 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is Gold Really Boring?]( investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. [See why this could be a huge untapped gold investing opportunity.]( --------------------------------------------------------------- [Iron Mountain]( Ticker: [IRM]( Recent Price: $66.25 Average Analyst Price Target: $65.00 (-3.02%) Market Cap: $19.34B Role Transaction Description No. of Shares Amount Date President & CEO, Director Informative Buy Non Open Market Buy 31,750 $1,540,828 2 Days Ago EVP, CHRO Informative Buy Non Open Market Buy 8,723 $580,603 5 Days Ago Recent Analyst Action: George Tong, analyst at Goldman Sachs, reiterates coverage on [Iron Mountain (IRM)]( in the Real Estate sector with a Buy rating and a price target of $73 (1 week ago). Here are 3rd party ratings for [IRM](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Bottom 37% (157 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Cenovus Energy]( Ticker: [CVE]( Recent Price: $15.89 Average Analyst Price Target: $23.62 (49.09%) Market Cap: $30.18B Role Transaction Description No. of Shares Amount Date President & CEO Informative Buy Buy 25,000 C$531,250 Yesterday Senior Vice-President Informative Buy Buy 5,000 C$108,500 Yesterday Non-Executive, Director Informative Buy Buy 10,302 C$224,939 2 Days Ago Recent Analyst Action: John Royall, analyst at J.P. Morgan, reiterates coverage on [Cenovus Energy (CVE)]( in the Energy sector with a Buy rating and a price target of $25.41 (1 day ago). Here are 3rd party ratings for [CVE](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 40% (99 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 AI Stock of 2023 (Not NVDA)]( It's not META, NVDA, GOOGL, or AMZN. But thanks to a major deal, this under-the-radar stock could go down as the #1 winner of the A.I. boom. [Click here to learn more...]( --------------------------------------------------------------- [Opko Health]( Ticker: [OPK]( Recent Price: $0.95 Average Analyst Price Target: $3.75 (293.25%) Market Cap: $737.19M Role Transaction Description No. of Shares Amount Date CEO & Chairman, Director, >10% Owner Informative Buy Non Open Market Buy 511,531 $475,724 2 Days Ago Chief Innovation Officer, Director Informative Buy Non Open Market Buy 216,184 $198,884 3 Days Ago Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Opko Health (OPK)]( in the Healthcare sector with a Buy rating and a price target of $3 (2 months ago). Here are 3rd party ratings for [OPK](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 39% (97 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Upbound Group]( Ticker: [UPBD]( Recent Price: $32.99 Average Analyst Price Target: $36.33 (10.12%) Market Cap: $1.79B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 912 $30,041 2 Days Ago Recent Analyst Action: Vincent Caintic, analyst at Stephens, reiterates coverage on [Upbound Group (UPBD)]( in the Technology sector with a Buy rating (1 week ago). Here are 3rd party ratings for [UPBD](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Bottom 4% (239 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Richest investors clearly worried about something big]( Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5.) [Click for full story.]( --------------------------------------------------------------- [Galiano Gold]( Ticker: [GAU]( Recent Price: $0.97 Average Analyst Price Target: $1.17 (53.05%) Market Cap: $215.33M Role Transaction Description No. of Shares Amount Date Chairman, Director Informative Buy Buy 165,500 $173,990 3 Days Ago Non-Executive, Director Informative Buy Buy 10,000 C$14,000 3 Days Ago Recent Analyst Action: Raj Ray, analyst at BMO Capital, reiterates coverage on [Galiano Gold (GAU)]( in the Basic Materials sector with a Buy rating and a price target of $1.12 (3 weeks ago). Here are 3rd party ratings for [GAU](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Vista Gold]( Ticker: [VGZ]( Recent Price: $0.37 Average Analyst Price Target: $2.00 (585.68%) Market Cap: $66.10M Role Transaction Description No. of Shares Amount Date Chairman, Director Informative Buy Buy 20,000 $7,324 2 Days Ago Director Informative Buy Non Open Market Buy 20,000 $7,200 2 Days Ago Recent Analyst Action: Heiko Ihle, analyst at H.C. Wainwright, reiterates coverage on [Vista Gold (VGZ)]( in the Basic Materials sector with a Buy rating and a price target of $2.5 (3 weeks ago). Here are 3rd party ratings for [VGZ](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [An Unusual Way to Invest in Gold]( financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines. [See why this overlooked gold play should be on every investor's radar.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software